Clinical trials
Phase 3 Carcinoma, Squamous Cell trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 1 |
| Incyte Corporation | 1 |
| Japan Clinical Oncology Group | 1 |
| Johnson & Johnson Enterprise Innovation Inc. | 1 |
| Pfizer | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 6 |
| Anus Neoplasms | 1 |
| Carcinoma, Adenosquamous | 1 |
| Carcinoma, Large Cell | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Esophageal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Head and Neck Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.